The Alzheimer’s Disease Assessment Scale’s cognitive subscale (ADAS-Cog) is the most widely used instrument for screening cognitive dysfunction in Alzheimer’s disease. The aim of the present study was to develop an Arabic version of this scale (A-ADAS-Cog), examine its psychometric properties (reliability and validity), and provide normative data. The A-ADAS-Cog), an Arabic version of the Mini-Mental State Examination (A-MMSE), and a Standardized Clinical Dementia Rating Scale (CDR) were administered to three Tunisian groups: 124 normal controls (NC), 33 patients with non-Alzheimer dementia (N-AD), and 25 patients with Alzheimer’s disease (AD). The A-ADAS-Cog scores were significantly affected by age and education. A correction table was constructed to control these effects. The results showed that the A-ADAS-Cog has good internal consistency and reliability (α= 0.82 for AD). The test-retest reliability of the A-ADAS-Cog was stable over time (r = 0.97). An evaluation of the construct validity of the A-ADAS-Cog using principal component analysis led to a solution with three factors (memory, language and praxis), which explained 72% of the variance. The concurrent validity of the A-ADAS-Cog was established using the A-MMSE score (r = –0.86), CDR Sum of Boxes score (CDR-SB; r = 0.87), and global CDR score (CDR-Global; r = 0.74). Finally, the A-ADAS-Cog has an excellent discriminating power in the diagnosis of AD (ROC area = 0.92). A cut-off score of 10 (sensitivity = 84% and specificity = 91%) is indicated for the screening of the AD. Overall, the results indicated that the A-ADAS-Cog is psychometrically reliable and valid and provides promising results for screening of dementia in Arabic speaking patients.
SternRG, MohsRC, DavidsonM, SchmeidlerJ, SilvermanJ, Kramer-GinsbergE, SearceyT, BiererL, DavisKL (1994) A longitudinal study of Alzheimer’s disease: Measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry151, 390–396.
6.
MohsRC (1996) The Alzheimer’s disease assessment scale. Int Psychogeriatr8, 195–203.
7.
DoraiswamyPM, BieberF, KaiserL, ConnorsK, KrishnanKR, Reuning-SchererJ, GulanskiB (1997) Memory, language, and praxis in Alzheimer’s disease: Norms for outpatient clinical trial populations. Psychopharmacol Bull33, 123–128.
8.
IhlR, Grass-KapankeB, JannerM, WeyerG (1999) Neuropsychometric tests in cross sectional and longitudinal studies - a regression analysis of ADAS-cog, SKT and MMSE. Pharmacopsychiatry32, 248–254.
9.
DoraiswamyPM, KaiserL, BieberF, GarmanRL (2001) The Alzheimer’s disease assessment scale: Evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer’s disease. Alzheimer Dis Assoc Disord15, 174–183.
10.
ZecRF, LandrethES, VicariSK, FeldmanE, BelmanJ, AndriseA, RobbsR, KumarV, BeckerR (1992) Alzheimer disease assessment scale: Useful for both early detection and staging of dementia of the Alzheimer type. Alzheimer Dis Assoc Disord6, 89–102.
11.
Pena-CasanovaJ (1997) Alzheimer’s Disease Assessment Scale–cognitive in clinical practice. Int Psychogeriatr9(Suppl 1), 105–114.
12.
KolibasE, KorinkovaV, NovotnyV, VajdickovaK, HunakovaD (2000) ADAS-cog (Alzheimer’s Disease Assessment Scale-cognitive subscale)-validation of the Slovak version. Bratisl Lek Listy101, 598–602.
13.
PascualLF, SazP, LarumbeR, Martinez-LageP, MuruzabalJ, MoralesF, LoboA, Martinez-LageJM, Sastre y HernandezM (1997) Standardization of the Alzheimer’s disease assessment scale in a spanish population. Neurologia12, 238–244.
14.
TsolakiM, FountoulakisK, NakopoulouE, KazisA, MohsRC (1997) Alzheimer’s Disease Assessment Scale: The validation of the scale in Greece in elderly demented patients and normal subjects. Dement Geriatr Cogn Disord8, 273–280.
15.
Groupe de Réflexion sur les Évaluations Cognitives – GRECO (1994) ADAS - Partie cognitive, Publication du GRECO, Paris.
16.
PuelM, Hugonot-DienerL (1996) Presentation by the GRECO group of the French adaptation of a cognitive assessment scale used in Alzheimer type dementia. Presse Med22, 1028–1032.
FioravantiM, NaccaD, BuckleyAE, FerrarioE, VarettoO, MogniP, FabrisF (1994) The Italian version of the Alzheimer’s Disease Assessment Scale (ADAS): Psychometric and normative characteristics from a normal aged population. Arch Gerontol Geriatr19, 21–30.
19.
ChuLW, ChiuKC, HuiSL, YuGK, TsuiWJ, LeePW (2000) The reliability and validity of the Alzheimer’s Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong. Ann Acad Med Singapore29, 474–485.
20.
SchultzRR, SivieroMO, BertolucciPH (2001) The cognitive subscale of the “Alzheimer’s Disease Assessment Scale” in a Brazilian sample. Braz J Med Biol Res34, 1295–1302.
21.
MaviogluH, GedizliogluM, AkyelS, AslanerT, EserE (2006) The validity and reliability of the Turkish version of Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer’s disease and normal subjects. Int J Geriatr Psychiatry21, 259–265.
22.
YountKM, SibaiAM (2009) Demography of aging in Arab countries. In International Handbook of Population Aging,
UhlenbergP., ed. Springer, Chapel Hill, pp. 277–315.
23.
Institut National de la Statistique, Données officielles relatives au recensement de 2004, http://www.ins.nat.tn/fr/rgpheduc4.php, Accessed February 12, 2016.
24.
United Nations Educational, Scientific and Cultural Organization (2016) Adult and Youth Literacy, 1990-2015: Analysis of data for 41 selected countries, UNESCO, Montreal.
25.
CheyJ, NaDR, ParkS, ParkE, LeeS (1999) Effects of education in dementia assessment: Evidence from standardizing the Korean-Dementia Rating Scale. Clin Neuropsychol13, 293–302.
26.
DoraiswamyPM, KrishenA, StalloneF, MartinWL, PottsNL, MetzA, DeVeaugh-GeissJ (1995) Cognitive performance on the Alzheimer’s Disease Assessment Scale: Effect of education. Neurology45, 1980–1984.
27.
DoraiswamyPM, BieberF, KaiserL, KrishnanKR, Reuning-SchererJ, GulanskiB (1997) The Alzheimer’s Disease Assessment Scale: Patterns and predictors of baseline cognitive performance in multicenter Alzheimer’s disease trials. Neurology48, 1511–1517.
28.
Pena-CasanovaJ, AguilarM, SantacruzP, Bertran-SerraI, HernandezG, SolJM, PujolA, BlesaR (1997) Adaptation and normalization of the Alzheimer’s disease Assessment Scale for Spain (NORMACODEM) (II). Neurologia12, 69–77.
29.
LiuHC, TengEL, ChuangYY, LinKN, FuhJL, WangPN (2002) The Alzheimer’s disease assessment scale: Findings from a low-education population. Dement Geriatr Cogn Disord13, 21–26.
30.
BellajT, SeronX (2014) Les facteurs culturels dans l’évaluation neuropsychologique. In Traité de neuropsychologie clinique de l’adulte,
SeronX.,
van der LindenM. eds. De Boeck-Solal, Marseille, pp. 641–658.
31.
GrahamDP, CullyJA, Lynn SnowA, MassmanP, DoodyR (2004) The Alzheimer’s Disease Assessment Scale - Cognitive subscale normative data for older adult controls. Alzheimer Dis Assoc Disord2(18), 236–240.
32.
HannesdottirK, SnædalJ (2002) A study of the Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population. Nord J Psychiatry56, 201–206.
33.
WangH, YuX, LiS, ChenY, LiH, HeJ (2004) The cognitive subscale of Alzheimer’s Disease Assessment Scale, Chinese Version in staging of Alzheimer disease. Alzheimer Dis Assoc Disord18, 231–235.
34.
FlahertyJA, GaviriaFM, PathakD, MitchellT, WintrobR, RichmanJA, BirzS (1988) Developing instruments for cross-cultural psychiatric research. J Nerv Ment Dis176, 257–263.
35.
AyadiS, BellajT, BouazizM, BouazizZ (2001) Analyse de 28 catégories sémantiques de l’arabe: Organisation catégorielle et lexicale. Laboratoire de Neuroscience. Faculté des Sciences Humaines et Sociales de Tunis, Tunis.
36.
ZanninoGD, PerriR, CaltagironeC, CarlesimoGA (2007) Category-specific naming deficit in Alzheimer’s disease: The effect of a display by domain interaction. Neuropsychologia45, 1832–1839.
37.
TippettLJ, MeierSL, BlackwoodK, Diaz-AsperC (2007) Category specific deficits in Alzheimer’s disease: Fact or artefact?Cortex43, 907–920.
38.
HernándezM, CostaA, JuncadellaM, Sebastián-GallésN, RenéR (2008) Category-specific semantic deficits in Alzheimer’s disease: A antic priming study. Neuropsychologia46, 935–946.
39.
LawsKR, GaleTM, LeesonVC, CrawfordJR (2005) When is category specific in Alzheimer’s disease?Cortex41, 452–463.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders - DSM-IV, APA, Washington, DC.
42.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
43.
NearyD, SnowdenJS, GustafsonL (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology51, 1546–1554.
44.
RomanGC, TatemichiTK, ErkinjunttiT, CummingsJL, MasdeuJC, GarciaJH, AmaducciL, OrgogozoJM, BrunA, HofmanA (1993) Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop. Neurology43, 250–260.
45.
BellajT, SeronX (2014) Les facteurs culturels dans l’évaluation neuropsychologique. In Traité de neuropsychologie clinique de l’adulte,
SeronX,
van der LindenM, eds. De Boeck-Solal, Marseille, pp. 641–658.
46.
McKeithIG, DicksonDW, LoweJ, EmreM, O’BrienJT, FeldmanH, CummingsJ, DudaJE, LippaC, PerryEK, AarslandD, AraiH, BallardCG, BoeveB, BurnDJ, CostaD, Del SerT, DuboisB, GalaskoD, GauthierS, GoetzCG, Gomez-TortosaE, HallidayG, HansenLA, HardyJ, IwatsuboT, KalariaRN, KauferD, KennyRA, KorczynA, KosakaK, LeeVM, LeesA, LitvanI, LondosE, LopezOL, MinoshimaS, MizunoY, MolinaJA, Mukaetova-LadinskaEB, PasquierF, PerryRH, SchulzJB, TrojanowskiJQ, YamadaM (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology65, 1863–1872.
47.
GauthierS, ReisbergB, ZaudigM, PetersenRC, RitchieK, BroichK, BellevilleS, BrodatyH, BennettD, ChertkowH, CummingsJL, de LeonM, FeldmanH, GanguliM, HampelH, ScheltensP, TierneyMC, WhitehouseP, WinbladB (2006) International Psychogeriatric Association Expert Conference on mild cognitive impairment. Lancet367, 1262–1270.
48.
DuboisB, FeldmanHH, JacovaC, DekoskyST, Barberger-GateauP, CummingsJ, DelacourteA, GalaskoD, GauthierS, JichaG, MeguroK, O’brienJ, PasquierF, RobertP, RossorM, SallowayS, SternY, VisserPJ, ScheltensP (2007) Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol6, 734–746.
49.
HughesCP, BergL, DanzigerWL, CobenLA, MartinRL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry140, 566–572.
50.
SchinkaJA (1984) Neuropsychological Status Examination, Psychological Assessment Resources, Odessa, FL.
51.
MelendezF (1978) Revised manual for the adult neuropsychological questionnaire, Psychological Assessment Resources, Odessa, FL.
52.
Attia-RomdhaneN, Ben HamoudaI, OuennicheS, Ben YoussefK, MhenniC, MrabetA (2008) Validation de l’échelle Clinical Dementia Rating en Tunisie. Tunis Med86(Suppl 07), 754–762.
53.
IBM Corp (2016) IBM SPSS Statistics forWindows, version 23, IBM Corp., Armonk, NY.
54.
BarthaR, SmithM, RupsinghR, RylettJ, WellsJL, BorrieMJ (2008) High field 1H MRS of the hippocampus after donepezil treatment in Alzheimer disease. Prog Neuropsychopharmacol Biol Psychiatry32, 786–793.
55.
BrackenBA, BaronaA (1991) State-of-the-art procedures for translating, validating, and using psychoeducational tests for cross-cultural assessment. Sch Psychol Int12, 119–132.
56.
Vaughn-CookeFB (1986) The challenge of assessing the language of nonmainstream speakers. In Treatment of Communication Disorders in Culturally and Linguistically Diverse Populations,
TaylorOL, ed. College-Hill Press, Boston, pp. 23–48.
57.
VerheyFR, HouxP, Van LangN, HuppertF, StoppeG, SaerensJ, BöhmP, De VreeseL, NordlundA, DeDeynPP, NeriM, Pena-CasanovaJ, WallinA, BollenE, MiddelkoopH, NargeotMC, PuelM, FleischmannUM, JollesJ (2004) Cross-national comparison and validation of the Alzheimer’s Disease Assessment Scale: Results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID). Int J Geriatr Psychiatry19, 41–50.
58.
YounJC, LeeDY, KimKW, LeeJH, JhooJH, LeeKU, HaJ, WooJI (2002) Development of the Korean version of Alzheimer’s disease Assessment Scale (ADAS-K). Int J Geriatr Psychiatry17, 797–803.
59.
LezakMD (1995), Neuropsychological assessment, Oxford University Press, New York.
60.
Van der LindenM, HupetM (1994) Le vieillissement cognitif, Presses Universitaires de France, Paris.
61.
SchwarbS, KöbereS, SpiegelR (1988) The Alzheimer’s Disease Assessment Scale (ADAS): An instrument for early diagnosis of dementia?Int J Geriatr Psychiatry3, 45–53.
